The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Down-regulation of KRAS-interacting miRNA-143 to predict prognosis and response to EGFR-targeted agents in colorectal cancer.
Florian Eisner
No relevant relationships to disclose
Michael Stotz
No relevant relationships to disclose
Hellmut Samonigg
No relevant relationships to disclose
Sigurd Lax
No relevant relationships to disclose
Gerald Hoefler
No relevant relationships to disclose
Martin Pichler
No relevant relationships to disclose